No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Sunflower Pharmaceutical Group Co., Ltd. is a Chinese enterprise dedicated to the comprehensive process of traditional Chinese medicine (TCM), covering everything from research and development to production and market distribution within China. The company's product range also extends to include chemical, biological, and health-focused pharmaceuticals. These diverse medications address a broad spectrum of medical needs, providing solutions in areas such as pediatrics, gynecology, digestive system ailments, respiratory issues including the common cold, conditions related to rheumatism and bone health, and cardiovascular and cerebrovascular disorders. The company's goods are sold under its established brands, "Sunflower" and "Little Sunflower." With its headquarters located in Harbin, China, Sunflower Pharmaceutical Group was founded in 2005.
www.kuihuayaoye.comNo one on the platform currently holds 002737.SZ.
No tracked institution reports a position in 002737.SZ as of their last filing.
No one on the platform has traded 002737.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -31.4% | -7.7% | ||||
| Profit Margin % | -11.1% | 11.2% | 11.8% | |||
| Free Cash Flow Margin % | 20.7% | 14.8% | 14.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $8.0B | +12.6% | $2.53 | $2.53–$2.53 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002737.SZSunflower Pharmaceutical Group Co.,Ltd | $11.25 | -0.53% | $6.6B | — |
| 000566.SZHainan Haiyao Co., Ltd. | $4.50 | -0.88% | $5.8B | — |
| 000597.SZNortheast Pharmaceutical Group Co., Ltd. | $4.60 | -0.43% | $6.6B | — |
| 000650.SZRenhe Pharmacy Co., Ltd. | $5.18 | -0.58% | $7.2B | — |
| 000915.SZShandong Wit Dyne Health Co.,Ltd. | $24.20 | -0.45% | $5.7B | — |
| 000989.SZJiuzhitang Co., Ltd. | $8.53 | -0.70% | $7.2B | — |
| 002004.SZHuapont Life Sciences Co., Ltd. | $4.35 | -0.46% | $8.6B | — |
Source: Financial Modeling Prep · peers by sector/industry